ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
38.62
0.39%
US Tech 100
17,796.00
0.16%
S&P 500
5,282.70
0.13%
US Dollar vs CAD
1.38421
-0.13%
Bitcoin
84,919.48
1.04%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Europe
  5. EU

  6. Vinci (DG) Share Price

Vinci

Vinci (DG)

Vinci
Dollar General Corporation
Dixie Gold Inc
119.70
-0.30
(-0.25%)
Closed April 17 10:30AM
Delayed by 15 minutes

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Key stats and details

Current Price
119.70
Bid
119.60
Ask
119.90
Volume
997,032
118.15 Day's Range 119.90
96.26 52 Week Range 120.30
Market Cap
68.44B
Previous Close
120.00
Open
118.65
Last Trade
418
@
119.7
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
1,218,808
Shares Outstanding
571,759,930
Dividend Yield
3.97%
PE Ratio
14.07
Earnings Per Share (EPS)
8.51
Revenue
72.91B
Net Profit
4.86B

About Vinci

Sector
Bldg Cnstr-gen Contr,op Bldr
Industry
Bldg Cnstr-gen Contr,op Bldr
Website
www.vinci.com
Headquarters
Nanterre, Hauts-de-seine, Fra
Founded
1908
Vinci is listed in the Bldg Cnstr-gen Contr,op Bldr sector of the Euronext with ticker DG. The last closing price for Vinci was 120.00 €. Over the last year, Vinci shares have traded in a share price range of 96.26 € to 120.30 €.

Vinci currently has 571,759,930 shares outstanding. The market capitalization of Vinci is 68.61 € billion. Vinci has a price to earnings ratio (PE ratio) of 14.07.

Ask ADVFN Intelligence (AI)

DG Latest News

More News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
16.655.88235294118113.05120.1110.81395696115.62490593DE
40.30.251256281407119.4120.31041553210113.7972265DE
1216.5516.0445952496103.15120.3101.951218808111.81581936DE
2612.611.7647058824107.1120.396.261065454106.36547232DE
527.56.68449197861112.2120.396.261010253106.55866374DE
15630.634.343434343489.1120.6280.84909930103.01583847DE
26046.0662.547528517173.64120.6264.86102138495.52121409DE

DG - Frequently Asked Questions (FAQ)

What is the current Vinci share price?
The current share price of Vinci is 119.70 €
How many Vinci shares are in issue?
Vinci has 571,759,930 shares in issue
What is the market cap of Vinci?
The market capitalisation of Vinci is EUR 68.61B
What is the 1 year trading range for Vinci share price?
Vinci has traded in the range of 96.26 € to 120.30 € during the past year
What is the PE ratio of Vinci?
The price to earnings ratio of Vinci is 14.07
What is the cash to sales ratio of Vinci?
The cash to sales ratio of Vinci is 0.94
What is the reporting currency for Vinci?
Vinci reports financial results in EUR
What is the latest annual turnover for Vinci?
The latest annual turnover of Vinci is EUR 72.91B
What is the latest annual profit for Vinci?
The latest annual profit of Vinci is EUR 4.86B
What is the registered address of Vinci?
The registered address for Vinci is 1973, BOULEVARD DE LA DEFENSE, CS 10268, NANTERRE, HAUTS-DE-SEINE, 92757
What is the Vinci website address?
The website address for Vinci is www.vinci.com
Which industry sector does Vinci operate in?
Vinci operates in the BLDG CNSTR-GEN CONTR,OP BLDR sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ALOPMOncodesign Precision Medicine SA
0.758 €
(53.13%)
90.4k
LHYFELhyfe SA
4.10 €
(29.95%)
158.39k
ALCABCabasse SA
0.52 €
(27.14%)
37.01k
ALVGVEOM Group
0.23 €
(18.62%)
93.08k
PLXPluxee NV
21.98 €
(18.11%)
269.8k
DMSBSDiagnostic Medical Systems
0.0035 €
(-30.00%)
30.63k
ALSENSensorion
0.17 €
(-26.09%)
1.49M
POXELPoxel
0.381 €
(-22.56%)
2.06M
ALALOAcheterLouerFR
0.0004 €
(-20.00%)
109.87M
ALQWAQwamplify Activation
1.95 €
(-18.73%)
280
ATOAtos SE
0.0036 €
(-7.69%)
596.11M
ALALOAcheterLouerFR
0.0004 €
(-20.00%)
109.87M
ALHPIHopium SA
0.0011 €
(-8.33%)
100.39M
ALVERVergnet
0.0006 €
(0.00%)
68.52M
BCPBanco Comercial Portugues SA
0.5358 €
(-1.90%)
66.58M

Discussion

View Full Feed
redspeed redspeed 2 minutes ago
Seems MONI common shareholders, not to be confused with MONI series B holders that are likely laughing, have quickly flew by stage 1 and 2, and currently in stage 3.

The seven stages of MONI bag holding…
Shock, denial, anger, bargaining, depression, guilt, and acceptance.
MONI
uber darthium uber darthium 2 minutes ago
That certainly isn’t any electric bill of any kind. Maybe the eloquent one Turdly V Columns “Turdvc” will show his philanthropic side and pay this off for his mentor

Just a suggestion
SPZI
halofan halofan 2 minutes ago
I agree with you that it’s very frustrating waiting for the announcement of new deals when we have been promised them for so long. But I am wondering if prospective partners are waiting for announcement of extension of patent and/or outcome of Merck patent dispute before signing. Just a thought.
HALO
north40000 north40000 2 minutes ago
I suspect a FTC subpoena directed to CVS would be informative as to respective prices of brand IPE and a generic RX IPE, with or without a particular insurance plan, or with Medicare plan XXX factored in.
CVS
GolfnutBoston GolfnutBoston 3 minutes ago
I don't know if you're familiar with Monster Beverage MNST but that went, I could be wrong, double zeroes to near $60 today without any type of split. We can only hope. Good luck to you. G-Can was up 70% this afternoon and a lot of newer people are in that so hopefully they'll bring profits back to
AFFU
beartrap12 beartrap12 3 minutes ago
From our friend, Hoffmann6383, through our other friend, Autologous Assassin on X:

Hoffmann6383:
The pressure is rising for NWBO detractors

$NWBO

✅Up ~90% in the last 13 calendar days

✅Awaiting imminent Regulatory Approval Decision
NWBO
jimmybob jimmybob 3 minutes ago
Afternoon Update: You're Fired! Edition--->

https://www.youtube.com/watch?v=n8X1gbD7N0E

$SPY $JNJ $GPCR $LLY $UNH
GPCR JNJ LLY
Hopeforthefuture3 Hopeforthefuture3 4 minutes ago
I also would like for Flipper to come back. It is my hope that this move is for the long awaited news of approval and that this move is just the start. Want to see trading in dollars and not pennies and no more quotes with 5 places after the decimal. For me it has been a long and painful 10+ years
NWBO
LTListener LTListener 4 minutes ago
Do you think maybe they already have the deal/NDA all lined up with a BP pending the finalization of the IND enabling studies with HEAL and that is why they went EM... Curious all this after the CEO interview and discussing how remarkable KRM-ll-81 is and opening "purse strings"?

I
RSPI
Masta SkillZ Masta SkillZ 5 minutes ago
yeah.. you're the one bs'n. It takes 5 seconds of research. The email address is on OTCmarkets website company profile and SINCs website. info@sincnano.com. It's a general company email but sometimes the CEO responds.
SINC
manibiotech manibiotech 6 minutes ago
Hi FlipIf you are still following this board . Don't want you to miss out possible eventual culmination of events . Please do come back . There will always be some differences in opinion , but your opinion was still factual. 
NWBO
GoodGuyBill GoodGuyBill 6 minutes ago
Which could mean they would have to spread the buying out over numerous days if not weeks. Good for NWBO!
NWBO
uber darthium uber darthium 6 minutes ago
Hi, I am a newbie here. My first post. Is MULN a good place to invest $1,000,000 ?


Thsnks
MULN
Seminole Red Seminole Red 7 minutes ago
whoa.....there no cut this week....everybodies in
Since 2012 Since 2012 7 minutes ago
Yea, you have a good wknd also, green till Monday, thanks for playing
CYDY
Investor2014 Investor2014 7 minutes ago
It takes a long time to test if humans in a clinical is ageing at a statistically different rate than their placebo cohort, something in the order of years and years and years.
AVXL
uber darthium uber darthium 8 minutes ago
Shhhhhhh !!! Don’t tell, let them figure that out for themselves

Umm, you're an anonymous user... 😂
HMBL
pumper_stumper pumper_stumper 8 minutes ago
And it's easy to fool these OTC "investors". Just talk science in your PRs and paid interviews. Not about how your product works, just in general talk about the science of how a drug would work. OTC investors are overwhelmed and can't digest the info... that results in them being impressed and c
FITY
GoodGuyBill GoodGuyBill 9 minutes ago
And then NWBO announces a $2+ billion Merck partnership first thing Monday morning!
NWBO
Humbert Humbert 9 minutes ago
Probably a MM, yes.
BNCM
MrMyers MrMyers 9 minutes ago
Correct. The restricted share price is $.003. Over 4B shares issued to platform investors.
IGPK
uber darthium uber darthium 9 minutes ago
I had lunch with Urban 2 months ago in Vegas. He stiffed me for it at the Auria.

Typical Urban
DAR53 DAR53 9 minutes ago
north, I do not take Vascepa but I went on the Humana site (my insurance) and they list as follows;
Screen pops up and states Generic is available, however, when you click Generic it shows as Not Covered but has a price for 1 Gram/ 30 Day Supply for $144.98.
Vascepa is listed as Covere
AMRN
H2R H2R 9 minutes ago
For fun: Stuttgart: up 75%

https://www.boerse-stuttgart.de/en/products/equities/stuttgart/a1j5ey-northwest-biother-dl--001

Best of luck to Patients, NWBO, and Longs!
NWBO

Your Recent History

EU
DG
Vinci
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub
Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads